Marshall syndrome

From WikiMD.org
Jump to navigation Jump to search

Marshall syndrome

Marshall syndrome (pronounced: /ˈmɑːrʃəl/ MAR-shəl) is a rare genetic disorder characterized by a range of distinctive facial features, ocular abnormalities, hearing loss, and early onset arthritis. The syndrome was first described by Richard E. Marshall and colleagues in 1958.

Etymology

The term "Marshall syndrome" is derived from the name of the physician who first described the condition, Dr. Richard E. Marshall.

Symptoms

Marshall syndrome is characterized by a range of symptoms, including:

Genetics

Marshall syndrome is caused by mutations in the COL11A1 gene. This gene provides instructions for making a protein that is used to form type XI collagen, a complex molecule that provides structure and strength to the body's tissues.

Diagnosis

Diagnosis of Marshall syndrome is based on clinical examination and genetic testing. The presence of the distinctive facial features, ocular abnormalities, hearing loss, and early onset arthritis are indicative of the condition. Genetic testing can confirm the diagnosis by identifying a mutation in the COL11A1 gene.

Treatment

Treatment for Marshall syndrome is symptomatic and supportive. This may include corrective lenses or surgery for ocular abnormalities, hearing aids for hearing loss, and physical therapy or surgery for arthritis.

See also

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski